MyAverix Finance
XETRA · Healthcare
Biofrontera AG (B8FK)
Drug Manufacturers - Specialty & Generic
Biofrontera AG (B8FK) is listed on XETRA in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for B8FK
Biofrontera AG (B8FK) — FAQ
What is B8FK's P/E ratio?
The price-to-earnings (P/E) ratio for Biofrontera AG (B8FK) is 18.00 (data as of 2026-05-24).
Does Biofrontera AG pay a dividend?
Dividend yield is not available in the current snapshot for Biofrontera AG (B8FK). Check the MyAverix Finance app for the latest dividend data.
What sector is Biofrontera AG in?
Biofrontera AG (B8FK) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is B8FK listed on?
B8FK is listed on XETRA.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.